Search alternatives:
mean decrease » a decrease (Expand Search)
fold decrease » fold increase (Expand Search), fold increased (Expand Search)
nn decrease » _ decrease (Expand Search), a decrease (Expand Search), gy decreased (Expand Search)
we decrease » _ decrease (Expand Search), a decrease (Expand Search), teer decrease (Expand Search)
2 fold » _ fold (Expand Search), 5 fold (Expand Search)
Showing 241 - 260 results of 21,690 for search '(( 50 ((nn decrease) OR (((we decrease) OR (mean decrease)))) ) OR ( 2 fold decrease ))', query time: 0.71s Refine Results
  1. 241
    Heatmap of fold-changes of metabolites.

    Heatmap of fold-changes of metabolites. by Elena Heidenreich (6940475)

    Published 2019
    “…<p>Fold-changes of metabolites in different pCO<sub>2</sub> (400 vs. 1000 μatm CO<sub>2</sub>) and light acclimations (LL vs. …”
    Save to List
    Saved in:
  2. 242
    Spike mutations within variants of concern.

    Spike mutations within variants of concern. by Chris Davis (647632)

    Published 2021
    Subjects:
    Save to List
    Saved in:
  3. 243
    CarE knockdown decreases the IC<sub>50</sub> value of DEF for inhibiting CarE activity in resistant aphids.

    CarE knockdown decreases the IC<sub>50</sub> value of DEF for inhibiting CarE activity in resistant aphids. by You-Hui Gong (619056)

    Published 2014
    Save to List
    Saved in:
  4. 244
    Mean plasma insulin concentration according to group during the maltodextrin tolerance test.

    Mean plasma insulin concentration according to group during the maltodextrin tolerance test. by Mark Lown (3772432)

    Published 2017
    Save to List
    Saved in:
  5. 245
    Mean plasma glucose concentrations according to group during the maltodextrin tolerance test.

    Mean plasma glucose concentrations according to group during the maltodextrin tolerance test. by Mark Lown (3772432)

    Published 2017
    Save to List
    Saved in:
  6. 246
    Combination of DNA Damage, Autophagy, and ERK Inhibition: Novel Evodiamine-Inspired Multi-Action Pt(IV) Prodrugs with High-Efficiency and Low-Toxicity Antitumor Activity

    Combination of DNA Damage, Autophagy, and ERK Inhibition: Novel Evodiamine-Inspired Multi-Action Pt(IV) Prodrugs with High-Efficiency and Low-Toxicity Antitumor Activity by Xiao-Meng Liu (778197)

    Published 2023
    “…Among them, compound <b>10</b> exhibited a 118-fold enhancement in the IC<sub>50</sub> value compared to cisplatin and low toxicity to normal cells. …”
    Save to List
    Saved in:
  7. 247
    Combination of DNA Damage, Autophagy, and ERK Inhibition: Novel Evodiamine-Inspired Multi-Action Pt(IV) Prodrugs with High-Efficiency and Low-Toxicity Antitumor Activity

    Combination of DNA Damage, Autophagy, and ERK Inhibition: Novel Evodiamine-Inspired Multi-Action Pt(IV) Prodrugs with High-Efficiency and Low-Toxicity Antitumor Activity by Xiao-Meng Liu (778197)

    Published 2023
    “…Among them, compound <b>10</b> exhibited a 118-fold enhancement in the IC<sub>50</sub> value compared to cisplatin and low toxicity to normal cells. …”
    Save to List
    Saved in:
  8. 248
    Combination of DNA Damage, Autophagy, and ERK Inhibition: Novel Evodiamine-Inspired Multi-Action Pt(IV) Prodrugs with High-Efficiency and Low-Toxicity Antitumor Activity

    Combination of DNA Damage, Autophagy, and ERK Inhibition: Novel Evodiamine-Inspired Multi-Action Pt(IV) Prodrugs with High-Efficiency and Low-Toxicity Antitumor Activity by Xiao-Meng Liu (778197)

    Published 2023
    “…Among them, compound <b>10</b> exhibited a 118-fold enhancement in the IC<sub>50</sub> value compared to cisplatin and low toxicity to normal cells. …”
    Save to List
    Saved in:
  9. 249
    Combination of DNA Damage, Autophagy, and ERK Inhibition: Novel Evodiamine-Inspired Multi-Action Pt(IV) Prodrugs with High-Efficiency and Low-Toxicity Antitumor Activity

    Combination of DNA Damage, Autophagy, and ERK Inhibition: Novel Evodiamine-Inspired Multi-Action Pt(IV) Prodrugs with High-Efficiency and Low-Toxicity Antitumor Activity by Xiao-Meng Liu (778197)

    Published 2023
    “…Among them, compound <b>10</b> exhibited a 118-fold enhancement in the IC<sub>50</sub> value compared to cisplatin and low toxicity to normal cells. …”
    Save to List
    Saved in:
  10. 250
    Combination of DNA Damage, Autophagy, and ERK Inhibition: Novel Evodiamine-Inspired Multi-Action Pt(IV) Prodrugs with High-Efficiency and Low-Toxicity Antitumor Activity

    Combination of DNA Damage, Autophagy, and ERK Inhibition: Novel Evodiamine-Inspired Multi-Action Pt(IV) Prodrugs with High-Efficiency and Low-Toxicity Antitumor Activity by Xiao-Meng Liu (778197)

    Published 2023
    “…Among them, compound <b>10</b> exhibited a 118-fold enhancement in the IC<sub>50</sub> value compared to cisplatin and low toxicity to normal cells. …”
    Save to List
    Saved in:
  11. 251
    Fold change of TIL subsets in paired TNBCs (N = 12 pts including 10 prim-met, and 2 met-met specimens) using log2 ratio of metastatic versus primary TNBC (n = 10, ●) or second recurrence versus first recurrence (n = 2, ■).

    Fold change of TIL subsets in paired TNBCs (N = 12 pts including 10 prim-met, and 2 met-met specimens) using log2 ratio of metastatic versus primary TNBC (n = 10, ●) or second recu... by Ting-Fang He (5210948)

    Published 2020
    Save to List
    Saved in:
  12. 252
    E<sub>50</sub> values.

    E<sub>50</sub> values. by Junxia Zhou (14381598)

    Published 2024
    Save to List
    Saved in:
  13. 253
    Predicted metabolite levels for each reaction intermediate shown in Figure 7 under conditions in which the NAD+:NADH ratio is 31 (Bennett et al. [26]), or decreased by either 0.1-fold or 0.01-fold.

    Predicted metabolite levels for each reaction intermediate shown in Figure 7 under conditions in which the NAD+:NADH ratio is 31 (Bennett et al. [26]), or decreased by either 0.1-f... by William R. Cannon (608586)

    Published 2014
    Save to List
    Saved in:
  14. 254
    Plot of mean compassion satisfaction by group and time.

    Plot of mean compassion satisfaction by group and time. by Kunal Desai (18784208)

    Published 2024
    Save to List
    Saved in:
  15. 255
    IFNγ+LPS up-regulated DEGs identified by RRA and fold-change analysis.

    IFNγ+LPS up-regulated DEGs identified by RRA and fold-change analysis. by Giorgia Colombo (6337118)

    Published 2024
    Save to List
    Saved in:
  16. 256
    P2X7 is functionally expressed in the ovarian carcinoma cell line SKOV-3.

    P2X7 is functionally expressed in the ovarian carcinoma cell line SKOV-3. by José David Nuñez-Ríos (18823719)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  17. 257
    HA-MAD1 tumors have increased CIN and decreased p53.

    HA-MAD1 tumors have increased CIN and decreased p53. by Sarah E. Copeland (13951506)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  18. 258
    Structure-Guided Discovery of Potent and Selective CLK2 Inhibitors for the Treatment of Knee Osteoarthritis

    Structure-Guided Discovery of Potent and Selective CLK2 Inhibitors for the Treatment of Knee Osteoarthritis by Yongqiang Sun (8226111)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  19. 259
    Structure-Guided Discovery of Potent and Selective CLK2 Inhibitors for the Treatment of Knee Osteoarthritis

    Structure-Guided Discovery of Potent and Selective CLK2 Inhibitors for the Treatment of Knee Osteoarthritis by Yongqiang Sun (8226111)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  20. 260
    Structure-Guided Discovery of Potent and Selective CLK2 Inhibitors for the Treatment of Knee Osteoarthritis

    Structure-Guided Discovery of Potent and Selective CLK2 Inhibitors for the Treatment of Knee Osteoarthritis by Yongqiang Sun (8226111)

    Published 2024
    Subjects:
    Save to List
    Saved in:

Search Tools: